Macrogenics News

Macrogenics | 8-K: Current report

May 23 16:31 ET

Macrogenics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

May 23 16:26 ET

Macrogenics | 8-K: MacroGenics Provides Update on Corporate Progress, First Quarter 2024 Financial Results and Interim TAMARACK Phase 2 Study Data

May 9 17:13 ET

Macrogenics | 8-K: Current report

May 9 16:13 ET

Macrogenics | DEF 14A: Definitive information statements

Apr 8 16:34 ET

Macrogenics | DEFA14A: Others

Apr 8 16:34 ET

Macrogenics | 8-K: Current report

Apr 3 17:30 ET

Macrogenics | 8-K: Current report

Mar 7 16:06 ET

Macrogenics | S-3: Registration statement for specified transactions by certain issuers

Nov 6, 2023 16:09 ET

Macrogenics | 8-K: MacroGenics Provides Update on Corporate Progress and Third Quarter 2023 Financial Results

Nov 6, 2023 16:04 ET

Macrogenics | 8-K: Current report

Sep 22, 2023 16:42 ET

Macrogenics | 8-K: MacroGenics Provides Update on Corporate Progress and Second Quarter 2023 Financial Results

Aug 9, 2023 16:04 ET

Macrogenics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Jun 6, 2023 16:11 ET

Macrogenics | 8-K: Current report

Jun 2, 2023 08:39 ET

Macrogenics | 8-K: MacroGenics Provides Update on Corporate Progress and First Quarter 2023 Financial Results

May 9, 2023 16:05 ET

Macrogenics | DEFA14A: Others

Apr 19, 2023 16:05 ET

Macrogenics | DEFA14A: Others

Apr 17, 2023 16:02 ET

Macrogenics | DEF 14A: Definitive proxy statements

Apr 17, 2023 16:01 ET

Macrogenics | 8-K: Current report

Mar 24, 2023 16:33 ET

Macrogenics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

Mar 15, 2023 17:19 ET